Clinicopathological features of solitary fibrous tumor of the meninges: An immunohistochemical reappraisal of cases previously diagnosed to be fibrous meningioma or hemangiopericytoma

• Published in: Pathology international 2000-10, Vol.50 (10), p.808-817
• Main Authors: Suzuki, Satoshi O., Fukui, Masashi, Nishio, Shunji, Iwaki, Toru
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor - analysis; Female; fibrous meningioma; hemangiopericytoma; Hemangiopericytoma - chemistry; Hemangiopericytoma - classification; Hemangiopericytoma - pathology; Hemangiopericytoma - surgery; Humans; Immunoenzyme Techniques; immunohistochemistry; Male; Meningeal Neoplasms - chemistry; Meningeal Neoplasms - classification; Meningeal Neoplasms - pathology; Meningeal Neoplasms - surgery; Meningioma - chemistry; Meningioma - classification; Meningioma - pathology; Meningioma - surgery; Middle Aged; Neoplasm Proteins - analysis; Neoplasm Recurrence, Local; solitary fibrous tumor
• ISSN: 1320-5463; 1440-1827
• DOI: 10.1046/j.1440-1827.2000.01120.x

Cases of solitary fibrous tumor (SFT) of the meninges are increasingly being reported. However, the real incidence of SFT among meningeal tumors has yet to be determined. We therefore clinicopathologically re‐examined 64 meningeal tumors originally diagnosed to be either fibrous meningioma (FM group, n= 46) or hemangiopericytoma (HPC group, n= 18) while paying special attention to SFT. We thus reclassified one case from the FM group (2%) and one case from the HPC group (6%) to be SFT, both of which showed diffuse CD34‐immunoreactivity and dense intercellular reticulin fibers but neither epithelial membrane antigen nor S‐100 protein expression. The MIB‐1 staining index of these cases were 6.2% and 3.9%, respectively. The former recurred 15 years after the initial surgery and the patient underwent a second removal of the tumor. The patient has been alive with no evidence of recurrence for 7 years after the second surgery. The latter patient has been alive with no evidence of recurrence for 3 years postoperatively. The results confirmed that the incidence of SFT among meningeal tumors is relatively low, however, because of its clinically indolent nature, a careful histochemical examination is necessary to differentiate SFT from other neoplasms with a more aggressive nature. Our findings emphasize the need to clinically recognize this lesion as a distinct entity.